Actuate Therapeutics, Inc.
ACTU • XNAS
Actuate Therapeutics, Inc. is a pharmaceutical preparations company trading on XNAS, led by CEO Daniel Schmitt, with a market cap of $44.8M.
Market Cap$44.8M
CEODaniel Schmitt
CountryUnited States of America
PHARMACEUTICAL PREPARATIONS
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
Actuate Therapeutics, Inc. FAQ
Common questions about Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 14, 2026.